For instance, IFNβ and IFNγ are two significant factors in TME that have been found to enhance the cytotoxicity of neutrophils, enabling them to combat early-stage breast cancer, lung cancer, and melanoma in both mouse and clinical models [168–170]. This evidence concerns the gene IFNB1 and lung carcinoma.